Should You Buy or Sell Akero Therapeutics Stock? Get The Latest AKRO Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Moody Aldrich Partners LLC acquired a new stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 19,994 shares of the company’s stock, valued at approximately $1,096,000. Other institutional investors and […]
MUFG Securities EMEA plc purchased a new stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 115,000 shares of the company’s stock, valued at approximately $6,302,000. MUFG Securities EMEA plc owned about 0.25% of […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) insider Catriona Yale sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 12th. The stock was sold at an average price of $43.23, for a total value of $216,150.00. Following the sale, the insider now directly owns 86,268 shares in the company, valued at […]
SG Americas Securities LLC acquired a new position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 21,415 shares of the company’s stock, valued at approximately $202,000. SG Americas Securities LLC owned approximately 0.06% […]